BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 18945890)

  • 1. Parkin deficiency increases vulnerability to inflammation-related nigral degeneration.
    Frank-Cannon TC; Tran T; Ruhn KA; Martinez TN; Hong J; Marvin M; Hartley M; Treviño I; O'Brien DE; Casey B; Goldberg MS; Tansey MG
    J Neurosci; 2008 Oct; 28(43):10825-34. PubMed ID: 18945890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of inflammation-related nigral degeneration and locomotor function in DJ-1(-/-) mice.
    Nguyen TA; Frank-Cannon T; Martinez TN; Ruhn KA; Marvin M; Casey B; Treviño I; Hong JJ; Goldberg MS; Tansey MG
    J Neuroinflammation; 2013 Apr; 10():50. PubMed ID: 23622116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of nigral degeneration in aged parkin/DJ-1/PINK1 triple knockout mice.
    Kitada T; Tong Y; Gautier CA; Shen J
    J Neurochem; 2009 Nov; 111(3):696-702. PubMed ID: 19694908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkin-knockout mice did not display increased vulnerability to intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Aguiar AS; Tristão FS; Amar M; Chevarin C; Lanfumey L; Mongeau R; Corti O; Prediger RD; Raisman-Vozari R
    Neurotox Res; 2013 Aug; 24(2):280-7. PubMed ID: 23588969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial artificial chromosome transgenic mice expressing a truncated mutant parkin exhibit age-dependent hypokinetic motor deficits, dopaminergic neuron degeneration, and accumulation of proteinase K-resistant alpha-synuclein.
    Lu XH; Fleming SM; Meurers B; Ackerson LC; Mortazavi F; Lo V; Hernandez D; Sulzer D; Jackson GR; Maidment NT; Chesselet MF; Yang XW
    J Neurosci; 2009 Feb; 29(7):1962-76. PubMed ID: 19228951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. rAAV-mediated nigral human parkin over-expression partially ameliorates motor deficits via enhanced dopamine neurotransmission in a rat model of Parkinson's disease.
    Manfredsson FP; Burger C; Sullivan LF; Muzyczka N; Lewin AS; Mandel RJ
    Exp Neurol; 2007 Oct; 207(2):289-301. PubMed ID: 17678648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral and neurotransmitter abnormalities in mice deficient for Parkin, DJ-1 and superoxide dismutase.
    Hennis MR; Seamans KW; Marvin MA; Casey BH; Goldberg MS
    PLoS One; 2013; 8(12):e84894. PubMed ID: 24386432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkin cooperates with GDNF/RET signaling to prevent dopaminergic neuron degeneration.
    Meka DP; Müller-Rischart AK; Nidadavolu P; Mohammadi B; Motori E; Ponna SK; Aboutalebi H; Bassal M; Annamneedi A; Finckh B; Miesbauer M; Rotermund N; Lohr C; Tatzelt J; Winklhofer KF; Kramer ER
    J Clin Invest; 2015 May; 125(5):1873-85. PubMed ID: 25822020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surprising behavioral and neurochemical enhancements in mice with combined mutations linked to Parkinson's disease.
    Hennis MR; Marvin MA; Taylor CM; Goldberg MS
    Neurobiol Dis; 2014 Feb; 62():113-23. PubMed ID: 24075852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral phenotyping of Parkin-deficient mice: looking for early preclinical features of Parkinson's disease.
    Rial D; Castro AA; Machado N; Garção P; Gonçalves FQ; Silva HB; Tomé AR; Köfalvi A; Corti O; Raisman-Vozari R; Cunha RA; Prediger RD
    PLoS One; 2014; 9(12):e114216. PubMed ID: 25486126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Running exercise protects the substantia nigra dopaminergic neurons against inflammation-induced degeneration via the activation of BDNF signaling pathway.
    Wu SY; Wang TF; Yu L; Jen CJ; Chuang JI; Wu FS; Wu CW; Kuo YM
    Brain Behav Immun; 2011 Jan; 25(1):135-46. PubMed ID: 20851176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkin-mediated protection of dopaminergic neurons in a chronic MPTP-minipump mouse model of Parkinson disease.
    Yasuda T; Hayakawa H; Nihira T; Ren YR; Nakata Y; Nagai M; Hattori N; Miyake K; Takada M; Shimada T; Mizuno Y; Mochizuki H
    J Neuropathol Exp Neurol; 2011 Aug; 70(8):686-97. PubMed ID: 21760537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted overexpression of the parkin substrate Pael-R in the nigrostriatal system of adult rats to model Parkinson's disease.
    Dusonchet J; Bensadoun JC; Schneider BL; Aebischer P
    Neurobiol Dis; 2009 Jul; 35(1):32-41. PubMed ID: 19348945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DJ-1 and Parkin modulate dopamine-dependent behavior and inhibit MPTP-induced nigral dopamine neuron loss in mice.
    Paterna JC; Leng A; Weber E; Feldon J; Büeler H
    Mol Ther; 2007 Apr; 15(4):698-704. PubMed ID: 17299411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-motor behavioural impairments in parkin-deficient mice.
    Zhu XR; Maskri L; Herold C; Bader V; Stichel CC; Güntürkün O; Lübbert H
    Eur J Neurosci; 2007 Oct; 26(7):1902-11. PubMed ID: 17883413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nigral degeneration and striatal dopaminergic dysfunction in idiopathic and Parkin-linked Parkinson's disease.
    Hu MT; Scherfler C; Khan NL; Hajnal JV; Lees AJ; Quinn N; Wood NW; Brooks DJ
    Mov Disord; 2006 Mar; 21(3):299-305. PubMed ID: 16211589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pael-R transgenic mice crossed with parkin deficient mice displayed progressive and selective catecholaminergic neuronal loss.
    Wang HQ; Imai Y; Inoue H; Kataoka A; Iita S; Nukina N; Takahashi R
    J Neurochem; 2008 Oct; 107(1):171-85. PubMed ID: 18691389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive dopamine neuron loss following supra-nigral lipopolysaccharide (LPS) infusion into rats exposed to LPS prenatally.
    Ling Z; Zhu Y; Tong Cw; Snyder JA; Lipton JW; Carvey PM
    Exp Neurol; 2006 Jun; 199(2):499-512. PubMed ID: 16504177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulator of G-protein signaling 10 promotes dopaminergic neuron survival via regulation of the microglial inflammatory response.
    Lee JK; McCoy MK; Harms AS; Ruhn KA; Gold SJ; Tansey MG
    J Neurosci; 2008 Aug; 28(34):8517-28. PubMed ID: 18716210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic reduction of mitochondrial complex I function does not lead to loss of dopamine neurons in vivo.
    Kim HW; Choi WS; Sorscher N; Park HJ; Tronche F; Palmiter RD; Xia Z
    Neurobiol Aging; 2015 Sep; 36(9):2617-27. PubMed ID: 26070241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.